Fig. 1From: Second- and third-generation ALK inhibitors for non-small cell lung cancerALK mutations in non-small cell lung cancer. Most mutations of the ALK gene are in the form of a translocation with another partner gene leading to a fusion oncogene. Most common fusion oncogenes in non-small cell lung cancer are presented in this diagramBack to article page